International Patent: PRECURSOR MOLECULE OF BOTULINUM TOXIN A1, NUCLEIC ACID MOLECULE, ENGINEERED RECOMBINANT BACULOVIRUS AND PREPARATION METHOD THEREFOR, AND METHOD FOR USING PRECURSOR MOLECULE TO PREPARE NATURAL BOTULINUM TOXIN A

GENEVA, June 26 -- BEIJING ANRATE BIOTECHNOLOGY CO., LTD. filed a patent application (CN2024/143991) for “PRECURSOR MOLECULE OF BOTULINUM TOXIN A1, NUCLEIC ACID MOLECULE, ENGINEERED RECOMBINANT BACULOVIRUS AND PREPARATION METHOD THEREFOR, AND METHOD FOR USING PRECURSOR MOLECULE TO PREPARE NATURAL BOTULINUM TOXIN A”. With publication no. WO/2026/118132, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/33

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....